期刊文献+

64排增强CT对进展期胃癌根治程度的判断价值 被引量:2

Judgement Value of Preoperative MDCT on Radical Resection Extent for Advanced Gastric Cancer
原文传递
导出
摘要 目的探讨64排增强CT(MDCT)对进展期胃癌(AGC)手术根治程度的判断价值。方法分析70例AGC患者MDCT增强扫描的影像学资料,判断N2(第7、8和9组)淋巴结转移及脏器受侵情况,并将CT判断结果与手术后病理结果进行比较。结果62例患者接受手术治疗,8例因手术禁忌证无法行手术治疗。MDCT术前判定N2淋巴结转移的敏感性为92.0%(46/50),特异性为75.0%(9/12),准确性为88.7%(55/62)。MDCT术前判定存在N2或以上淋巴结转移者81.6%(40/49)行D2以上扩大根治术;判定N2淋巴结无转移者92.3%(12/13)行标准D2根治术。结论MDCT对诊断AGC N2淋巴结转移及周围脏器侵犯有重要价值,对AGC手术根治程度的判定有指导作用。 Objective To evaluate the role of preoperative 64 multi-detector spiral CT(MDCT) in predicting the extent of radical resection for advanced gastric cancer(AGC).Methods The imaging data of 70 patients with AGC were collected and analyzed.The N2 lymph node metastasis was predicted by the MDCT indications,and compared with that postoperative pathological results.Results Sixty-two patients were treated with surgical intervention.The sensitivity,specificity,and accuracy of N2 positive prediction by MDCT was 92.0%(46/50),75.0%(9/12) and 88.7%(55/62),respectively.Extended resection was performed in 81.6%(40/49) patients who were predicted as N2 positive,and D2 resection was performed in 92.3%(12/13) patients who were predicted as N2 negative.Conclusion The MDCT is a valuable technique to predict N2 lymph node metastasis,and to determine the extent of resection for AGC.
出处 《中国普外基础与临床杂志》 CAS 2010年第1期25-28,共4页 Chinese Journal of Bases and Clinics In General Surgery
关键词 胃癌 淋巴结转移 根治术 计算机断层扫描 Gastric cancer Lymph node metatasis Radical resection Computed tomography
  • 相关文献

参考文献26

  • 1Park JM, Kim YH. Current approaches to gastric cancer in Korea[J]. Gastrolntest Cancer Res, 2008; 2(3): 137-144.
  • 2Diaz de Liano A, Yarnoz C, Aguilar R, et al. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer [J]. Gastric Cancer, 2008; 11(2): 96- 102.
  • 3季加孚.胃癌外科的现状与发展趋势[J].中国普外基础与临床杂志,2006,13(1):1-3. 被引量:65
  • 4朱正纲.胃癌外科治疗相关问题的基本认识[J].中国普外基础与临床杂志,2008,15(1):1-3. 被引量:17
  • 5Kunisaki C, Akiyama H, Nomura M, etal. Comparison of surgical results of D2 versus D3 gastreetomy (para-aortic lymph node dissection) for advanced gastric carcinoma. A multi-institutional study [J]. Ann Surg Oncol, 2006; 13(7): 659 -667.
  • 6Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aor tic lymphaden-ectomy Japan Clinical Oncology Group study 9501 [J]. J ClinOncol, 2004; 22(14): 2767-2773.
  • 7Ueda Y, Fujimura T, Kinami S, et al. A randomized phase Ⅲ trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage Ⅱ /Ⅲ A gastric cancer, Hokuriku- Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC) [J]. Jpa J Clin Oncol, 2006, 36(8):519-522.
  • 8Ajani JA, Moiseyenko VM, Tjulandin S, etal. Clinical ben efit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase Ⅲ trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V- 325 Study Group [J]. J Clin Oncol, 2007; 25(22):3205-3209.
  • 9Bouche O, Ychou M, Burtin P, Bedenne L, etal. Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery a lone for gastric cancer: 7year results of the FFCD randomized phase Ⅲ trial (8801) [J]. Ann Oncol, 2005, 16(9): 1488 -1497.
  • 10Habermann CR, Weiss F, Rieeken R, et al. Preoperative staging of gastric adenoearcinoma: comparison of helical CT and endoscopic US[J]. Radiology, 2004.230(2): 465-471.

二级参考文献55

共引文献98

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部